Sincalide Patent Expiration
Sincalide was first introduced by Bracco Diagnostics Inc
Sincalide Patents
Given below is the list of patents protecting Sincalide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Sincalide | US11110063 | Storage stable sincalide formulations | Apr 20, 2038 | Maia Pharms Inc |
Sincalide | US11318100 | Storage stable sincalide formulations | Apr 20, 2038 | Maia Pharms Inc |
Sincalide | US11737983 | Storage stable sincalide formulations | Apr 20, 2038 | Maia Pharms Inc |
Kinevac | US6803046 | Sincalide formulations |
Aug 16, 2022
(Expired) | Bracco |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sincalide's patents.
Latest Legal Activities on Sincalide's Patents
Given below is the list recent legal activities going on the following patents of Sincalide.
Activity | Date | Patent Number |
---|---|---|
Email Notification Critical | 29 Aug, 2023 | US11737983 |
Patent eGrant Notification | 29 Aug, 2023 | US11737983 |
Recordation of Patent eGrant | 29 Aug, 2023 | US11737983 |
Patent Issue Date Used in PTA Calculation Critical | 29 Aug, 2023 | US11737983 |
Mail Patent eGrant Notification | 29 Aug, 2023 | US11737983 |
Recordation of Patent Grant Mailed Critical | 29 Aug, 2023 | US11737983 |
Electronic Review Critical | 10 Aug, 2023 | US11737983 |
Email Notification Critical | 10 Aug, 2023 | US11737983 |
Issue Notification Mailed Critical | 09 Aug, 2023 | US11737983 |
Application Is Considered Ready for Issue Critical | 14 Jul, 2023 | US11737983 |